Conclusion
our study showed that pharmacist-driven ASP in febrile neutropenic patients could improve antibiotic appropriateness in both empirical and documentation therapy. However, 30-day infectious diseases-related mortality and length of stay were not different between the groups. Although target antibiotic utilization in the intervention group increased, we found a reduction in total antibiotic utilization in the pharmacist-driven ASP group.
Acknowledgements: We thank the primary physicians who practicing in the medical wards during study period at Thammasat University Hospital.
Funding: No financial support was provided relevant to this article.
Data availability statement: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.